June 28, 2023
SES success as EHA2023
EHA2023 in Frankfurt, Germany was an incredible success for us personally at SES! On the Friday evening and with a packed auditorium, we delivered a live, hybrid Lymphoma Hub and Multiple Myeloma Hub symposium on: The ins and outs of CAR T cells in the real world.
The success of this event cemented the fact that IME symposia attract HCPs in droves!
We are now gearing up to upscale this offering to our industry supporters; from the smaller congresses to the biggest, we have the ability to develop and implement truly thought-provoking content that addresses clinical gaps. Our use of pre- and post-test questioning allows us to measure the learning outcomes delivered. Our recent symposium saw participants increase their knowledge by an average of 21% on the topic of metabolic tumor volume and 89% of respondents felt they could use what they had heard in the symposium in their clinical practice.
Please get in touch with the partnerships team to find out more about how you can support: email@example.com
SES and FOCIS: Working together to deliver IME in immune-mediated diseases
SES is an independent medical education agency with a strong heritage in hematology and a growing presence in immunology.
Our global, open-access online platforms provide balanced, credible, and up-to-date medical education in their respective indications. In 2022, we successfully launched our first platforms within the immunology space; first the Psoriasis and Psoriatic Arthritis Hub, followed by the Lupus Hub.
Across our portfolio of IME platforms, we are reaching over 244,000 unique users across 190 countries annually. In 2023, we plan to launch a dedicated IBD Hub, which will be the first of its kind in the IBD field, with another hub focussing on multiple sclerosis to follow.
We could not do this without our vital partnerships with international societies and patient groups from across the world, which allow us to create innovative educational initiatives that give rise to empowered communities, stronger networks, and greater collaboration opportunities.
Guiding our journey into the immunology space via the Lupus Hub has been our overarching partnership with the Federation of Clinical Immunology Societies (FOCIS). Through FOCIS, researchers and clinicians share knowledge across traditional disease borders and identify commonalities between treatments and therapies that are life-changing for those impacted by immune-mediated diseases.
FOCIS has 62 member societies, representing roughly 65,000 clinician scientists, which is critical in ensuring we can share education as far as possible and reach communities that we might not otherwise be able to.
Part of our support was to attend the 23rd Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS 2023), which took place on June 20–23, 2023, at the Boston Marriott Copley Place, Boston, US.
The SES team were delighted to connect with the FOCIS community to share details of our collaboration in delivering IME in lupus, IBD, and cancer immunotherapy.
If you would like to know more about our work in these areas, please email us at firstname.lastname@example.org
Looking to receive the latest news, project updates, and new offerings?